tiprankstipranks
Biotech Alert: Searches spiking for these stocks today
PremiumThe FlyBiotech Alert: Searches spiking for these stocks today
1M ago
OS Therapies price target raised to $15 from $8 at Maxim
Premium
The Fly
OS Therapies price target raised to $15 from $8 at Maxim
1M ago
OS Therapies announces OST-HER2 trial achieves primary endpoint
Premium
The Fly
OS Therapies announces OST-HER2 trial achieves primary endpoint
1M ago
OS Therapies: Last patient in OST-HER2 OS trial completes last patient visit
PremiumThe FlyOS Therapies: Last patient in OST-HER2 OS trial completes last patient visit
5M ago
OS Therapies announces development of two ADC therapeutic candidate
Premium
The Fly
OS Therapies announces development of two ADC therapeutic candidate
5M ago
OS Therapies announces efficacy, safety data for ovarian cancer candidate
Premium
The Fly
OS Therapies announces efficacy, safety data for ovarian cancer candidate
5M ago
OS Therapies accepted into Johnson & Johnson JLABS
PremiumThe FlyOS Therapies accepted into Johnson & Johnson JLABS
6M ago
OS Therapies reports Q2 EPS (26c) vs. (47c) last year
Premium
The Fly
OS Therapies reports Q2 EPS (26c) vs. (47c) last year
6M ago
OS Therapies announces osteosarcoma Scientific and Medical Advisory Board
Premium
The Fly
OS Therapies announces osteosarcoma Scientific and Medical Advisory Board
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100